Globus Medical (GMED) Long-Term Investments (2013 - 2026)

Globus Medical has reported Long-Term Investments for 14 years, with the latest figure at $169.4 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments changed N/A year-over-year to $169.4 million; the trailing twelve-month figure through Mar 2026 stood at $169.4 million (changed N/A YoY), and the FY2025 full-year result was $71.8 million, up 8.6% from the prior year.
• Long-Term Investments for Q1 2026 stood at $169.4 million, up from $71.8 million in the prior quarter.
• The five-year high for Long-Term Investments was $546.9 million in Q1 2022, with the low at $12.3 million in Q3 2024.
• Historically, Long-Term Investments has averaged $243.9 million across 5 years, with a median of $169.4 million in 2026.
• Annual changes were most pronounced in 2024 — Long-Term Investments tumbled 95.54% — and 2025, when it surged 35.68%.
• Globus Medical's Long-Term Investments stood at $495.9 million in 2022, then slumped by 84.79% to $75.4 million in 2023, then declined by 12.32% to $66.1 million in 2024, then gained by 8.6% to $71.8 million in 2025, then soared by 135.92% to $169.4 million in 2026.
• The last three Long-Term Investments figures came in at $169.4 million (Q1 2026), $71.8 million (Q4 2025), and $16.7 million (Q3 2025), per Business Quant data.